These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26003815)

  • 1. Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method.
    Solymosi T; Angi R; Basa-Dénes O; Ránky S; Ötvös Z; Glavinas H; Filipcsei G; Heltovics G
    Eur J Pharm Biopharm; 2015 Aug; 94():135-40. PubMed ID: 26003815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel continuous flow technology for the development of a nanostructured aprepitant formulation with improved pharmacokinetic properties.
    Angi R; Solymosi T; Ötvös Z; Ordasi B; Glavinas H; Filipcsei G; Heltovics G; Darvas F
    Eur J Pharm Biopharm; 2014 Apr; 86(3):361-8. PubMed ID: 24161498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved oral absorption and chemical stability of everolimus via preparation of solid dispersion using solvent wetting technique.
    Jang SW; Kang MJ
    Int J Pharm; 2014 Oct; 473(1-2):187-93. PubMed ID: 25003829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supersaturatable formulations for the enhanced oral absorption of sirolimus.
    Kim MS; Kim JS; Cho W; Cha KH; Park HJ; Park J; Hwang SJ
    Int J Pharm; 2013 Mar; 445(1-2):108-16. PubMed ID: 23396259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation.
    Hu X; Lin C; Chen D; Zhang J; Liu Z; Wu W; Song H
    Int J Pharm; 2012 Nov; 438(1-2):123-33. PubMed ID: 22850296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
    Dong Y; Ng WK; Hu J; Shen S; Tan RB
    Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
    Kim MS; Kim JS; Park HJ; Cho WK; Cha KH; Hwang SJ
    Int J Nanomedicine; 2011; 6():2997-3009. PubMed ID: 22162657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.
    Tong HH; Du Z; Wang GN; Chan HM; Chang Q; Lai LC; Chow AH; Zheng Y
    Int J Pharm; 2011 Feb; 404(1-2):148-58. PubMed ID: 21094233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems.
    Sun M; Si L; Zhai X; Fan Z; Ma Y; Zhang R; Yang X
    Drug Dev Ind Pharm; 2011 Aug; 37(8):986-94. PubMed ID: 21417621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxypropyl methylcellulose mediated precipitation inhibition of sirolimus: from a screening campaign to a proof-of-concept human study.
    Petruševska M; Homar M; Petek B; Resman A; Kocjan D; Urleb U; Peternel L
    Mol Pharm; 2013 Jun; 10(6):2299-310. PubMed ID: 23586335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
    Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
    Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines in renal transplant rejection--focus on sirolimus.
    Shen LJ; Wu FL
    Int J Nanomedicine; 2007; 2(1):25-32. PubMed ID: 17722509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal.
    Zhang J; Lv H; Jiang K; Gao Y
    Int J Pharm; 2011 Nov; 420(1):180-8. PubMed ID: 21878378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics.
    Ahmed OA; Hosny KM; Al-Sawahli MM; Fahmy UA
    Drug Des Devel Ther; 2015; 9():655-62. PubMed ID: 25670883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis.
    Tejani A; Alexander S; Ettenger R; Lerner G; Zimmerman J; Kohaut E; Briscoe DM
    Pediatr Transplant; 2004 Apr; 8(2):151-60. PubMed ID: 15049795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.
    Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F
    Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology versus other techniques in improving drug dissolution.
    Kwok PC; Chan HK
    Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.